Tilt Investment Management Holdings PBC Has $268,000 Stake in Colgate-Palmolive (NYSE:CL)

Tilt Investment Management Holdings PBC trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 23.2% in the fourth quarter, HoldingsChannel reports. The firm owned 3,362 shares of the company’s stock after selling 1,018 shares during the period. Tilt Investment Management Holdings PBC’s holdings in Colgate-Palmolive were worth $268,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CL. Vest Financial LLC increased its stake in shares of Colgate-Palmolive by 25.1% in the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock valued at $29,498,000 after buying an additional 74,337 shares during the period. Central Bank & Trust Co. increased its stake in shares of Colgate-Palmolive by 22.1% in the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after buying an additional 250 shares during the period. Dynamic Advisor Solutions LLC increased its stake in shares of Colgate-Palmolive by 9.2% in the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock valued at $864,000 after buying an additional 910 shares during the period. Sarasin & Partners LLP boosted its position in shares of Colgate-Palmolive by 1.2% in the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after purchasing an additional 49,980 shares during the last quarter. Finally, Cornerstone Wealth Management LLC boosted its position in shares of Colgate-Palmolive by 2.5% in the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after purchasing an additional 172 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

CL stock opened at $86.30 on Friday. The stock has a 50-day moving average price of $87.02 and a 200-day moving average price of $80.67. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $90.37. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. The firm has a market cap of $70.94 billion, a PE ratio of 31.19, a price-to-earnings-growth ratio of 3.26 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating the consensus estimate of $0.85 by $0.02. The company had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The firm’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same period last year, the business posted $0.77 EPS. As a group, equities research analysts expect that Colgate-Palmolive will post 3.49 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date of this dividend is Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s payout ratio is presently 69.06%.

Insider Transactions at Colgate-Palmolive

In other news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the transaction, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Noel R. Wallace sold 69,948 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the sale, the chief executive officer now directly owns 286,881 shares in the company, valued at approximately $24,161,117.82. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock worth $19,505,099 in the last 90 days. Insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

CL has been the topic of several recent research reports. The Goldman Sachs Group initiated coverage on Colgate-Palmolive in a research report on Friday, March 1st. They issued a “buy” rating and a $93.00 price target on the stock. UBS Group lifted their target price on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, January 29th. StockNews.com lowered Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Evercore ISI lifted their target price on Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a report on Monday, April 8th. Finally, Barclays lifted their target price on Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday, April 12th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average target price of $89.50.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.